Walleye Trading LLC Olema Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$10.53 - $17.14 $133,836 - $217,849	-12,710 Reduced 85.28%	2,193 $30,000
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $122,055 - $193,440	14,903 New	14,903 $184,000
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $160,501 - $389,081	-41,260 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $361,025 - $1.27 Million	41,260 New	41,260 $386,000

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.